- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Establishing Self-Care Plans For Treatment
During this segment, Genevieve Kumapley, PharmD, BCOP, discusses the significance of introducing a self-care plan to patients who are undergoing cancer treatment.
“There is a value in helping the patient understand what their anticipated side effects are, when to expect them, and how to manage them,” says Dr Kumapley, who notes the importance of proper planning in an era in which oral oncolytics have become primary treatment options.
Dr Kumapley remarks that if established at the beginning of treatment, a self-care plan has the potential to improve overall patient adherence. Currently, she notes, nonadherence rates are up to 30% in patients who are treated with oral oncolytics.
Self-care plans can have a significant impact on the patient’s likelihood of experiencing severe symptoms and can help decrease unnecessary healthcare resource utilization, adds Dr Kumapley.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
